Navigating Challenges for Small Countries to Ac...

By João L. Carapinha

July 31, 2025

Access to innovative medicines is a pressing issue for patients in smaller European countries. These nations often face significant barriers in obtaining timely and equitable healthcare solutions. The article "Ensuring access to innovative medicin...
Mental Health Policy Integration: A Cross-Sector Imperative for Well-being an...
Urgent Call to Action for EU Clinical Trials Strategy
National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in...
Silencing Science Impact: Political Interference and Global Health Consequences
10-Year Health Plan: Transforming England’s NHS for the Future
EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030
Pharma Ad Spending Trends: Insights from the Top 10 Drug Advertisers of 2024
Dutch Health Disruption: Reimagining Care with Social Entrepreneurship
Pharmaceutical Industry Europe: Key Insights and Future Challenges for 2025
Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR
Private Health Funding Under South Africa’s National Health Insurance Act
Impending Net Drug Price Transparency Regulation in the U.S.